Federal Register MedWatch Pharma News Warning Letters
Remodulin (treprostinil sodium) Injection, 1.0, 2.5, 5.0, and 10.0 mg/ml United Therapeutics NDA 21-272
For the most up-to-date approval information, please locate this API using the drug index.